Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fungal melanin biosynthesis pathway is a critical metabolic route responsible for the production of melanin, a high-molecular-weight pigment essential for fungal survival and pathogenicity [Henson et al., 1999]. In most filamentous fungi, melanin is synthesized via the 1,8-dihydroxynaphthalene (DHN) pathway, while certain yeasts like Cryptococcus neoformans utilize the L-3,4-dihydroxyphenylalanine (DOPA) pathway [Langfelder et al., 2003]. Melanin functions as a biological shield, protecting the fungus from environmental insults such as ultraviolet (UV) radiation, extreme temperatures, and oxidative stress [Nosanchuk & Casadevall, 2003]. Within a host, melanin acts as a potent virulence factor by neutralizing reactive oxygen species produced by immune cells and masking fungal components to evade detection [Upadhyay et al., 2023]. Pharmacological inhibition of this pathway, primarily through melanin biosynthesis inhibitors (MBIs) like tricyclazole, disrupts the formation of the protective pigment, thereby reducing the fungus's ability to infect hosts and survive environmental stress [Henson et al., 1999]. While currently most prevalent in agricultural applications to combat rice blast, this pathway represents a promising target for developing novel clinical antifungals that attenuate virulence rather than directly killing the organism.
Inhibition of specific enzymes within the melanin biosynthetic route, such as 1,3,8-trihydroxynaphthalene reductase (3HNR) or scytalone dehydratase (SDH), which prevents the polymerization of 1,8-dihydroxynaphthalene into melanin [Henson et al., 1999; Upadhyay et al., 2023].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal melanin biosynthesis pathway (DHN/DOPA pathway).